Skip to main content

Journey Medical Corp(DERM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Journey Medical Corporation Reports First Quarter 2022 Financial Results and Recent Corporate Highlights

Globe Newswire - Tue May 10, 2022

Generated record revenue of $23.3 million for the first quarter of 2022

First patient dosed in Phase 3 clinical program evaluating DFD-29 for the treatment of papulopustular rosacea

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe